| 0 |
FORDYCE SPOTS |
1 |
0.1429 |
| 1 |
PRODUCT PROCESS CONTROL ISSUE |
1 |
0.0833 |
| 2 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
329 |
0.0594 |
| 3 |
EYELID SCAR |
1 |
0.0263 |
| 4 |
MALABSORPTION FROM APPLICATION SITE |
4 |
0.0261 |
| 5 |
PURGING |
2 |
0.0192 |
| 6 |
PRODUCT USE COMPLAINT |
286 |
0.0181 |
| 7 |
PSEUDOFOLLICULITIS |
1 |
0.0159 |
| 8 |
HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION |
4 |
0.0111 |
| 9 |
PELVIC FLOOR DYSFUNCTION |
2 |
0.0094 |
| 10 |
ORAL ALLERGY SYNDROME |
1 |
0.0090 |
| 11 |
APPLICATION SITE ACNE |
4 |
0.0082 |
| 12 |
POOR QUALITY PRODUCT ADMINISTERED |
84 |
0.0080 |
| 13 |
DEVELOPMENTAL REGRESSION |
1 |
0.0074 |
| 14 |
SIMPLE PARTIAL SEIZURES |
5 |
0.0062 |
| 15 |
RENAL PAPILLARY NECROSIS |
1 |
0.0047 |
| 16 |
PRODUCT PHYSICAL ISSUE |
78 |
0.0039 |
| 17 |
PRODUCT STORAGE ERROR |
333 |
0.0038 |
| 18 |
DERMAL ABSORPTION IMPAIRED |
1 |
0.0036 |
| 19 |
ANDROGENETIC ALOPECIA |
1 |
0.0035 |
| 20 |
LIQUID PRODUCT PHYSICAL ISSUE |
25 |
0.0034 |
| 21 |
ACNE CYSTIC |
10 |
0.0033 |
| 22 |
PRODUCT APPEARANCE CONFUSION |
3 |
0.0032 |
| 23 |
PRODUCT DEPOSIT |
5 |
0.0032 |
| 24 |
DISCONTINUED PRODUCT ADMINISTERED |
1 |
0.0030 |
| 25 |
SKIN STRIAE |
4 |
0.0027 |
| 26 |
CHEMICAL BURN |
3 |
0.0026 |
| 27 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 28 |
ACNE PUSTULAR |
2 |
0.0024 |
| 29 |
SPHINCTER OF ODDI DYSFUNCTION |
1 |
0.0024 |
| 30 |
MEIBOMIAN GLAND DYSFUNCTION |
1 |
0.0022 |
| 31 |
POST INFLAMMATORY PIGMENTATION CHANGE |
1 |
0.0022 |
| 32 |
CHLOASMA |
1 |
0.0022 |
| 33 |
HYPERMOBILITY SYNDROME |
1 |
0.0020 |
| 34 |
THERAPY CESSATION |
86 |
0.0017 |
| 35 |
PERIORAL DERMATITIS |
1 |
0.0016 |
| 36 |
HYPOTRICHOSIS |
1 |
0.0016 |
| 37 |
VULVAL DISORDER |
1 |
0.0015 |
| 38 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 39 |
SEBORRHOEA |
5 |
0.0014 |
| 40 |
VITAMIN B COMPLEX DEFICIENCY |
1 |
0.0013 |
| 41 |
PRESCRIPTION FORM TAMPERING |
1 |
0.0013 |
| 42 |
DRUG TOLERANCE INCREASED |
1 |
0.0013 |
| 43 |
PRODUCT ADMINISTRATION INTERRUPTED |
10 |
0.0013 |
| 44 |
PUSTULE |
3 |
0.0013 |
| 45 |
THYROID HORMONES DECREASED |
1 |
0.0013 |
| 46 |
SINUSITIS FUNGAL |
1 |
0.0012 |
| 47 |
PROCEDURAL NAUSEA |
1 |
0.0012 |
| 48 |
ADRENAL SUPPRESSION |
1 |
0.0012 |
| 49 |
PRODUCT CONTAMINATION PHYSICAL |
3 |
0.0012 |
| 50 |
SKIN WOUND |
2 |
0.0012 |
| 51 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
6 |
0.0012 |
| 52 |
TERMINAL INSOMNIA |
2 |
0.0011 |
| 53 |
APPLICATION SITE DISCOMFORT |
2 |
0.0011 |
| 54 |
PRODUCT OUTER PACKAGING ISSUE |
1 |
0.0011 |
| 55 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 56 |
HAIR GROWTH ABNORMAL |
7 |
0.0010 |
| 57 |
AUTONOMIC NEUROPATHY |
1 |
0.0010 |
| 58 |
STEROID WITHDRAWAL SYNDROME |
1 |
0.0010 |
| 59 |
THYROID HORMONES INCREASED |
1 |
0.0010 |
| 60 |
APPLICATION SITE PAPULES |
1 |
0.0009 |
| 61 |
SKIN EROSION |
3 |
0.0009 |
| 62 |
APPLICATION SITE DRYNESS |
3 |
0.0009 |
| 63 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 64 |
PRODUCT CONTAINER ISSUE |
7 |
0.0008 |
| 65 |
PRODUCT USE ISSUE |
153 |
0.0008 |
| 66 |
TRISOMY 21 |
1 |
0.0008 |
| 67 |
COUNTERFEIT PRODUCT ADMINISTERED |
1 |
0.0008 |
| 68 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 69 |
CORNEAL ABRASION |
1 |
0.0007 |
| 70 |
DISCHARGE |
1 |
0.0007 |
| 71 |
INTERMENSTRUAL BLEEDING |
4 |
0.0007 |
| 72 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 73 |
APPLICATION SITE REACTION |
5 |
0.0007 |
| 74 |
PRODUCT DISPENSING ISSUE |
3 |
0.0007 |
| 75 |
EXPIRED PRODUCT ADMINISTERED |
22 |
0.0007 |
| 76 |
AMENORRHOEA |
11 |
0.0006 |
| 77 |
PRODUCT DOSE OMISSION ISSUE |
184 |
0.0006 |
| 78 |
ACNE |
46 |
0.0006 |
| 79 |
SUPRAVENTRICULAR EXTRASYSTOLES |
2 |
0.0006 |
| 80 |
TREATMENT DELAYED |
1 |
0.0006 |
| 81 |
SCRATCH |
6 |
0.0006 |
| 82 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 83 |
HYPERTRICHOSIS |
1 |
0.0005 |
| 84 |
PRODUCT LEAKAGE |
3 |
0.0005 |
| 85 |
ATROPHY |
1 |
0.0005 |
| 86 |
SKIN IRRITATION |
23 |
0.0005 |
| 87 |
REBOUND ATOPIC DERMATITIS |
1 |
0.0005 |
| 88 |
PRODUCT QUALITY ISSUE |
67 |
0.0005 |
| 89 |
APPLICATION SITE EXFOLIATION |
2 |
0.0005 |
| 90 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 91 |
YELLOW SKIN |
2 |
0.0004 |
| 92 |
PRODUCT PACKAGING ISSUE |
4 |
0.0004 |
| 93 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 94 |
PAINFUL RESPIRATION |
1 |
0.0004 |
| 95 |
HORMONE LEVEL ABNORMAL |
2 |
0.0004 |
| 96 |
JUVENILE IDIOPATHIC ARTHRITIS |
1 |
0.0004 |
| 97 |
PRODUCT SOLUBILITY ABNORMAL |
2 |
0.0004 |
| 98 |
DERMATOMYOSITIS |
1 |
0.0004 |
| 99 |
MENOPAUSE |
1 |
0.0004 |
| 100 |
BREAST SWELLING |
1 |
0.0004 |
| 101 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 102 |
SKIN ATROPHY |
2 |
0.0003 |
| 103 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 104 |
WRONG PATIENT RECEIVED PRODUCT |
1 |
0.0003 |
| 105 |
FACIAL PAIN |
3 |
0.0003 |
| 106 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
2 |
0.0003 |
| 107 |
PRODUCT DISPENSING ERROR |
7 |
0.0003 |
| 108 |
PRODUCT FORMULATION ISSUE |
2 |
0.0003 |
| 109 |
SKIN INJURY |
1 |
0.0003 |
| 110 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
10 |
0.0003 |
| 111 |
THERAPY INTERRUPTED |
21 |
0.0003 |
| 112 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 113 |
MENSTRUATION DELAYED |
3 |
0.0003 |
| 114 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 115 |
SKIN BURNING SENSATION |
19 |
0.0003 |
| 116 |
POLYDIPSIA |
1 |
0.0003 |
| 117 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 118 |
CONDITION AGGRAVATED |
76 |
0.0002 |
| 119 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 120 |
PERIPHERAL VENOUS DISEASE |
1 |
0.0002 |
| 121 |
TRIGGER FINGER |
1 |
0.0002 |
| 122 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 123 |
MENSTRUAL DISORDER |
2 |
0.0002 |
| 124 |
HORDEOLUM |
1 |
0.0002 |
| 125 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 126 |
IRON DEFICIENCY |
1 |
0.0002 |
| 127 |
HEAVY MENSTRUAL BLEEDING |
2 |
0.0002 |
| 128 |
SKIN ABRASION |
1 |
0.0002 |
| 129 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 130 |
FOOT OPERATION |
1 |
0.0002 |
| 131 |
INABILITY TO AFFORD MEDICATION |
2 |
0.0002 |
| 132 |
INITIAL INSOMNIA |
2 |
0.0002 |
| 133 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 134 |
TENDERNESS |
2 |
0.0002 |
| 135 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 136 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 137 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 138 |
SKIN LACERATION |
2 |
0.0002 |
| 139 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 140 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
3 |
0.0002 |
| 141 |
SCAR |
3 |
0.0002 |
| 142 |
MICTURITION URGENCY |
2 |
0.0002 |
| 143 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 144 |
CYST |
2 |
0.0002 |
| 145 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 146 |
SKIN EXFOLIATION |
13 |
0.0002 |
| 147 |
SOMNAMBULISM |
1 |
0.0002 |
| 148 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 149 |
ERYTHEMA |
30 |
0.0001 |
| 150 |
DERMATITIS |
3 |
0.0001 |
| 151 |
SKIN REACTION |
2 |
0.0001 |
| 152 |
PAPULE |
1 |
0.0001 |
| 153 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 154 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 155 |
SENSITIVE SKIN |
1 |
0.0001 |
| 156 |
SUNBURN |
1 |
0.0001 |
| 157 |
BREAST TENDERNESS |
1 |
0.0001 |
| 158 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 159 |
SKIN DISORDER |
4 |
0.0001 |
| 160 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 161 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 162 |
DRUG ERUPTION |
2 |
0.0001 |
| 163 |
DRY SKIN |
15 |
0.0001 |
| 164 |
MENSTRUATION IRREGULAR |
3 |
0.0001 |
| 165 |
DRUG INEFFECTIVE |
146 |
0.0001 |
| 166 |
LUPUS-LIKE SYNDROME |
1 |
0.0001 |
| 167 |
HIDRADENITIS |
1 |
0.0001 |
| 168 |
SKIN DISCOLOURATION |
5 |
0.0001 |
| 169 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 170 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 171 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 172 |
APPENDICITIS |
1 |
0.0001 |
| 173 |
ACCIDENTAL EXPOSURE TO PRODUCT |
11 |
0.0001 |
| 174 |
DISEASE RECURRENCE |
5 |
0.0001 |
| 175 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 176 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 177 |
FOLLICULITIS |
1 |
0.0001 |
| 178 |
BREAST PAIN |
1 |
0.0001 |
| 179 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 180 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 181 |
SKIN INFECTION |
1 |
0.0001 |
| 182 |
REBOUND EFFECT |
1 |
0.0001 |
| 183 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 184 |
SURGERY |
5 |
0.0001 |
| 185 |
WRIST FRACTURE |
1 |
0.0001 |
| 186 |
THERAPEUTIC RESPONSE DECREASED |
5 |
0.0001 |
| 187 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 188 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 189 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 190 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 191 |
GASTRITIS |
2 |
0.0001 |
| 192 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 193 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 194 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 195 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 196 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 197 |
PARALYSIS |
1 |
0.0001 |
| 198 |
PRODUCT SUBSTITUTION ISSUE |
4 |
0.0001 |
| 199 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 200 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 201 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 202 |
THYROID DISORDER |
1 |
0.0001 |
| 203 |
GYNAECOMASTIA |
2 |
0.0001 |
| 204 |
ABSCESS |
1 |
0.0001 |
| 205 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 206 |
SWELLING FACE |
4 |
0.0001 |
| 207 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 208 |
FACE OEDEMA |
1 |
0.0001 |
| 209 |
INFLAMMATION |
3 |
0.0001 |
| 210 |
NIGHTMARE |
2 |
0.0001 |
| 211 |
RASH |
25 |
0.0001 |
| 212 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 213 |
PRODUCT ADHESION ISSUE |
2 |
0.0001 |
| 214 |
RASH PRURITIC |
3 |
0.0001 |
| 215 |
PELVIC PAIN |
1 |
0.0001 |
| 216 |
DYSURIA |
2 |
0.0001 |
| 217 |
FEELING JITTERY |
1 |
0.0001 |
| 218 |
INCREASED APPETITE |
1 |
0.0001 |
| 219 |
EYE IRRITATION |
3 |
0.0001 |
| 220 |
SKIN FISSURES |
1 |
0.0001 |
| 221 |
PRURITUS |
19 |
0.0000 |
| 222 |
FEEDING DISORDER |
1 |
0.0000 |
| 223 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 224 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 225 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 226 |
ANGIOEDEMA |
2 |
0.0000 |
| 227 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 228 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 229 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 230 |
OFF LABEL USE |
38 |
0.0000 |
| 231 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 232 |
SEIZURE |
5 |
0.0000 |
| 233 |
HYPERSENSITIVITY |
8 |
0.0000 |
| 234 |
BURNING SENSATION |
3 |
0.0000 |
| 235 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 236 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 237 |
DRY EYE |
2 |
0.0000 |
| 238 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 239 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 240 |
SEDATION |
1 |
0.0000 |
| 241 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 242 |
MOOD ALTERED |
1 |
0.0000 |
| 243 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 244 |
SKIN LESION |
1 |
0.0000 |
| 245 |
BLISTER |
2 |
0.0000 |
| 246 |
LETHARGY |
2 |
0.0000 |
| 247 |
DYSSTASIA |
1 |
0.0000 |
| 248 |
DISEASE PROGRESSION |
4 |
0.0000 |
| 249 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 250 |
INJECTION SITE RASH |
1 |
0.0000 |
| 251 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 252 |
MIGRAINE |
3 |
0.0000 |
| 253 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 254 |
INSOMNIA |
8 |
0.0000 |
| 255 |
FUNGAL INFECTION |
1 |
0.0000 |
| 256 |
URTICARIA |
5 |
0.0000 |
| 257 |
HEART RATE DECREASED |
1 |
0.0000 |
| 258 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 259 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 260 |
INJECTION SITE MASS |
1 |
0.0000 |
| 261 |
DYSGEUSIA |
2 |
0.0000 |
| 262 |
EYE SWELLING |
1 |
0.0000 |
| 263 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 264 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 265 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 266 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
5 |
0.0000 |
| 267 |
ANXIETY |
7 |
0.0000 |
| 268 |
OSTEOPOROSIS |
1 |
0.0000 |
| 269 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 270 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 271 |
MENTAL DISORDER |
1 |
0.0000 |
| 272 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 273 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 274 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 275 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 276 |
FATIGUE |
17 |
0.0000 |
| 277 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 278 |
PAIN |
13 |
0.0000 |
| 279 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 280 |
DYSPHAGIA |
2 |
0.0000 |
| 281 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 282 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 283 |
ALOPECIA |
4 |
0.0000 |
| 284 |
HEART RATE INCREASED |
2 |
0.0000 |
| 285 |
SINUSITIS |
2 |
0.0000 |
| 286 |
HAEMORRHAGE |
2 |
0.0000 |
| 287 |
ECZEMA |
1 |
0.0000 |
| 288 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 289 |
MEDICATION ERROR |
1 |
0.0000 |
| 290 |
INFLUENZA |
2 |
0.0000 |
| 291 |
EYE PAIN |
1 |
0.0000 |
| 292 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 293 |
DEPRESSION |
4 |
0.0000 |
| 294 |
IRRITABILITY |
1 |
0.0000 |
| 295 |
DISCOMFORT |
1 |
0.0000 |
| 296 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 297 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 298 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 299 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 300 |
VISION BLURRED |
2 |
0.0000 |
| 301 |
SLEEP DISORDER |
1 |
0.0000 |
| 302 |
DIZZINESS |
7 |
0.0000 |
| 303 |
MALAISE |
6 |
0.0000 |
| 304 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 305 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 306 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 307 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 308 |
DECREASED APPETITE |
3 |
0.0000 |
| 309 |
DRUG INTERACTION |
2 |
0.0000 |
| 310 |
DRY MOUTH |
1 |
0.0000 |
| 311 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 312 |
TREATMENT FAILURE |
1 |
0.0000 |
| 313 |
MYALGIA |
2 |
0.0000 |
| 314 |
BALANCE DISORDER |
1 |
0.0000 |
| 315 |
COVID-19 |
2 |
0.0000 |
| 316 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 317 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 318 |
MUSCLE SPASMS |
2 |
0.0000 |
| 319 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 320 |
WEIGHT DECREASED |
3 |
0.0000 |
| 321 |
BREAST CANCER |
1 |
0.0000 |
| 322 |
COUGH |
3 |
0.0000 |
| 323 |
SWELLING |
1 |
0.0000 |
| 324 |
DYSPNOEA |
6 |
0.0000 |
| 325 |
NAUSEA |
8 |
0.0000 |
| 326 |
SOMNOLENCE |
2 |
0.0000 |
| 327 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 328 |
ILLNESS |
1 |
0.0000 |
| 329 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 330 |
HEADACHE |
6 |
0.0000 |
| 331 |
CONSTIPATION |
2 |
0.0000 |
| 332 |
WEIGHT INCREASED |
2 |
0.0000 |
| 333 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 334 |
PYREXIA |
3 |
0.0000 |
| 335 |
PALPITATIONS |
1 |
0.0000 |
| 336 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 337 |
ASTHENIA |
3 |
0.0000 |
| 338 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 339 |
HYPERHIDROSIS |
1 |
0.0000 |
| 340 |
PSORIASIS |
1 |
0.0000 |
| 341 |
ARTHRALGIA |
3 |
0.0000 |
| 342 |
INFECTION |
1 |
0.0000 |
| 343 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 344 |
VOMITING |
3 |
0.0000 |
| 345 |
PNEUMONIA |
2 |
0.0000 |
| 346 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 347 |
CHEST PAIN |
1 |
0.0000 |
| 348 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 349 |
HYPERTENSION |
1 |
0.0000 |
| 350 |
BACK PAIN |
1 |
0.0000 |
| 351 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 352 |
FEELING ABNORMAL |
1 |
0.0000 |
| 353 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 354 |
DIARRHOEA |
2 |
0.0000 |
| 355 |
FALL |
1 |
0.0000 |